207 related articles for article (PubMed ID: 15680261)
1. Inhibition of glutamate carboxypeptidase II (NAALADase) protects against dynorphin A-induced ischemic spinal cord injury in rats.
Long JB; Yourick DL; Slusher BS; Robinson MB; Meyerhoff JL
Eur J Pharmacol; 2005 Jan; 508(1-3):115-22. PubMed ID: 15680261
[TBL] [Abstract][Full Text] [Related]
2. Dynorphin A-induced rat spinal cord injury: evidence for excitatory amino acid involvement in a pharmacological model of ischemic spinal cord injury.
Long JB; Rigamonti DD; Oleshansky MA; Wingfield CP; Martinez-Arizala A
J Pharmacol Exp Ther; 1994 Apr; 269(1):358-66. PubMed ID: 7909561
[TBL] [Abstract][Full Text] [Related]
3. 2-phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Mohamed M; Czuczwar SJ
Eur J Pharmacol; 2006 Feb; 531(1-3):66-73. PubMed ID: 16403497
[TBL] [Abstract][Full Text] [Related]
4. Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-alpha-linked-acidic dipeptidase (NAALADASE).
Slusher BS; Thomas A; Paul M; Schad CA; Ashby CR
Synapse; 2001 Jul; 41(1):22-8. PubMed ID: 11354010
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury.
Slusher BS; Vornov JJ; Thomas AG; Hurn PD; Harukuni I; Bhardwaj A; Traystman RJ; Robinson MB; Britton P; Lu XC; Tortella FC; Wozniak KM; Yudkoff M; Potter BM; Jackson PF
Nat Med; 1999 Dec; 5(12):1396-402. PubMed ID: 10581082
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism.
Xi ZX; Li X; Peng XQ; Li J; Chun L; Gardner EL; Thomas AG; Slusher BS; Ashby CR
J Neurochem; 2010 Jan; 112(2):564-76. PubMed ID: 19895667
[TBL] [Abstract][Full Text] [Related]
7. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Cai Z; Lin S; Rhodes PG
Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
[TBL] [Abstract][Full Text] [Related]
9. Spinal N-acetyl-alpha-linked acidic dipeptidase (NAALADase) inhibition attenuates mechanical allodynia induced by paw carrageenan injection in the rat.
Yamamoto T; Nozaki-Taguchi N; Sakashita Y
Brain Res; 2001 Aug; 909(1-2):138-44. PubMed ID: 11478930
[TBL] [Abstract][Full Text] [Related]
10. NAALADase inhibition protects motor neurons against chronic glutamate toxicity.
Thomas AG; Corse AM; Coccia CF; Bilak MM; Rothstein JD; Slusher BS
Eur J Pharmacol; 2003 Jun; 471(3):177-84. PubMed ID: 12826236
[TBL] [Abstract][Full Text] [Related]
11. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
[TBL] [Abstract][Full Text] [Related]
12. [Effect of neurotoxin on spinal cord injury in rats].
Ye X; Li M; Li J
Zhonghua Wai Ke Za Zhi; 1998 Jan; 36(1):31-4. PubMed ID: 11715537
[TBL] [Abstract][Full Text] [Related]
13. Topical application of dynorphin A (1-17) antiserum attenuates trauma induced alterations in spinal cord evoked potentials, microvascular permeability disturbances, edema formation and cell injury: an experimental study in the rat using electrophysiological and morphological approaches.
Winkler T; Sharma HS; Gordh T; Badgaiyan RD; Stålberg E; Westman J
Amino Acids; 2002; 23(1-3):273-81. PubMed ID: 12373547
[TBL] [Abstract][Full Text] [Related]
14. Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA).
Rais R; Rojas C; Wozniak K; Wu Y; Zhao M; Tsukamoto T; Rudek MA; Slusher BS
J Pharm Biomed Anal; 2014 Jan; 88():162-9. PubMed ID: 24055700
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta.
Thomas AG; Liu W; Olkowski JL; Tang Z; Lin Q; Lu XC; Slusher BS
Eur J Pharmacol; 2001 Oct; 430(1):33-40. PubMed ID: 11698060
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection produced by the NAALADase inhibitor 2-PMPA in rat cerebellar neurons.
Tortella FC; Lin Y; Ved H; Slusher BS; Dave JR
Eur J Pharmacol; 2000 Aug; 402(1-2):31-7. PubMed ID: 10940354
[TBL] [Abstract][Full Text] [Related]
17. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
[TBL] [Abstract][Full Text] [Related]
18. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
19. GCP II inhibition rescues neurons from gp120IIIB-induced neurotoxicity.
Thomas AG; Bodner A; Ghadge G; Roos RP; Slusher BS
J Neurovirol; 2009 Sep; 15(5-6):449-57. PubMed ID: 19995130
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
